The partnership will evaluate whether imaging- and biomarker-informed insights can support a more personalised approach to ...

ROCHESTER — Mayo Clinic and GE HealthCare will conduct research on an emerging treatment for prostate cancer and how that treatment can become more personalized to each patient, the two ...

A US government study finds racial disparities in care and a complicated relationship between distance to major cancer centers and patients’ treatment and outcomes.

Federal health officials are quietly moving to overhaul the fine print on testosterone replacement therapy, a shift that ...

In the United States, prostate cancer is a leading cause of cancer-related disease and death in men. About half of prostate ...

Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine ...

The study is aimed at advancing personalized cancer treatment by exploring a personalized approach to radioligand therapy.

NeoGenomics launched PTEN IHC CDx, the first IHC companion diagnostic test approved by the U.S. FDA for patients with ...

Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...

Scientists at the University of Illinois Chicago have turned an unlikely source into a potential new weapon against cancer: ...

An enhanced telehealth model demonstrates feasibility and high clinician and patient acceptability for prostate cancer management.

The state has been extending a short-term emergency contract with Centurion Health since July 2025 after backing out of a ...